» Articles » PMID: 32169065

Sustained HIV Viral Suppression Among Men Who Have Sex with Men in the Miami-Dade County Ryan White Program: the Effect of Demographic, Psychosocial, Provider and Neighborhood Factors

Overview
Publisher Biomed Central
Specialty Public Health
Date 2020 Mar 15
PMID 32169065
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HIV viral suppression is associated with health benefits for people living with HIV and a decreased risk of HIV transmission to others. The objective was to identify demographic, psychosocial, provider and neighborhood factors associated with sustained viral suppression among gay, bisexual, and other men who have sex with men.

Methods: Data from adult men who have sex with men (MSM) enrolled in the Miami-Dade County Ryan White Program (RWP) before 2017 were used. Sustained viral suppression was defined as having an HIV viral load < 200 copies/ml in all viral load tests in 2017. Three-level (individual, medical case management site, and neighborhood) cross-classified mixed-effect models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for sustained viral suppression.

Results: Of 3386 MSM, 90.8% were racial/ethnic minorities, and 84.4% achieved sustained viral suppression. The odds of achieving sustained viral suppression was lower for 18-24 and 25-34 year-old MSM compared with 35-49 year-old MSM, and for non-Latino Black MSM compared with White MSM. Those not enrolled in the Affordable Care Act, and those with current AIDS symptoms and a history of AIDS had lower odds of achieving sustained viral suppression. Psychosocial factors significantly associated with lower odds of sustained viral suppression included drug/alcohol use, mental health symptoms, homelessness, and transportation to appointment needs. Individuals with an HIV physician who serves a larger volume of RWP clients had greater odds of sustained viral suppression. Neighborhood factors were not associated with sustained viral suppression.

Conclusion: Despite access to treatment, age and racial disparities in sustained viral suppression exist among MSM living with HIV. Addressing substance use, mental health, and social services' needs may improve the ability of MSM to sustain viral suppression long-term. Furthermore, physician characteristics may be associated with HIV outcomes and should be explored further.

Citing Articles

Depressive Symptoms and HIV Viral Suppression: A Systematic Review and Meta-analysis.

Huang B, Younger A, Gallant M, OGrady T AIDS Behav. 2024; 29(3):870-883.

PMID: 39690344 PMC: 11830644. DOI: 10.1007/s10461-024-04571-0.


Empowering a Limpopo rural community to Integrate Ubuntu in caring for PLWHIV/AIDS or TB.

Ramavhoya T, Kgatla M, Rasweswe M, Mulaudzi F Curationis. 2024; 47(2):e1-e7.

PMID: 39625092 PMC: 11736542. DOI: 10.4102/curationis.v47i2.2628.


Estimation of place-based vulnerability scores for HIV viral non-suppression: an application leveraging data from a cohort of people with histories of using drugs.

Nguyen T, Roberts Lavigne L, Brantner C, Kirk G, Mehta S, Linton S BMC Med Res Methodol. 2024; 24(1):21.

PMID: 38273277 PMC: 10809603. DOI: 10.1186/s12874-023-02133-x.


Access to Federally Qualified Health Centers and HIV Outcomes in the U.S. South.

Kiernan J, Dahman B, Krist A, Neigh G, Kimmel A Am J Prev Med. 2023; 66(5):770-779.

PMID: 38101464 PMC: 11034789. DOI: 10.1016/j.amepre.2023.12.008.


The Impact of HIV-Related Stigma on Racial/Ethnic Disparities in Retention in HIV Care Among Adults Living with HIV in Florida.

Forney D, Sheehan D, Dale S, Li T, De La Rosa M, Spencer E J Racial Ethn Health Disparities. 2023; 11(4):2498-2508.

PMID: 37495905 PMC: 10811278. DOI: 10.1007/s40615-023-01715-1.


References
1.
Yehia B, Fleishman J, Metlay J, Moore R, Gebo K . Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012; 308(4):339-42. PMC: 3541503. DOI: 10.1001/jama.2012.5927. View

2.
Bradley H, Mattson C, Beer L, Huang P, Shouse R . Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection. AIDS. 2016; 30(13):2117-24. PMC: 5084085. DOI: 10.1097/QAD.0000000000001164. View

3.
Philbin M, Tanner A, DuVal A, Ellen J, Kapogiannis B, Fortenberry J . Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care. AIDS Care. 2013; 26(1):12-9. PMC: 3872213. DOI: 10.1080/09540121.2013.808730. View

4.
Crepaz N, Tang T, Marks G, Mugavero M, Espinoza L, Hall H . Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013. Clin Infect Dis. 2016; 63(7):976-83. PMC: 5021630. DOI: 10.1093/cid/ciw418. View

5.
Park L, Tate J, Sigel K, Brown S, Crothers K, Gibert C . Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study. Ann Intern Med. 2018; 169(2):87-96. PMC: 6825799. DOI: 10.7326/M16-2094. View